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Abstract
Background: Extra-cellular components, such as serum and exosome, have drawn great attention as a readily
accessible source of biomarkers for mammalian health. However, the contribution of different blood components to
the signature of respective microRNAs (miRNAs) remains unknown, especially in cattle. In this study we aimed to
investigate the miRNAs from bovine sera and exosomes, and to provide insights into their future applications.
Results: Blood collected from four healthy dairy cows were used for this study. The serum and exosomal RNAs
were extracted using two commonly used commercial kits (Norgen and Invitrogen total RNA isolation kit),
respectively. The miRNA profiles were then generated using RNA-seq. Sera had higher complexity of miRNAome
consisting of 328 ± 17 miRNAs, while less number of miRNAs (260 ± 15, P = 0.001) was detected in exosomes. The
profile of total detected miRNAs in sera and exosomes was different, while exosomes represented about 78 % of
total miRNAs expressed in sera, suggesting that exosomes are the major miRNAs carriers in bovine sera. A total of
24 and 3 miRNAs (RPM > 5) were exclusively expressed in sera and exosomes, respectively. In addition, 12 miRNAs
were differentially expressed between sera and exosomes (FDR < 0.05), with the expression of four of them being
further validated by stem-loop RT-qPCR. Moreover, functional analysis showed that uniquely and highly expressed
miRNAs in sera were mainly related to diseases and disorders, while the predicted functions of those in exosomes
were enriched in tissue development and lipid metabolism.
Conclusion: Our results provide evidence that bovine sera and exosomes miRNAomes are different with regarding
to the miRNA numbers, types and expressions. Based on their distinct profiles, miRNAs from sera and exosomes
may reflect different aspects of physiological and pathological conditions in cattle. The functional analysis suggest
that sera may be preferable for the purpose of detecting inflammation in cattle, while exosomes may be a better
choice for monitoring the status of muscle development and lipid metabolism.
Background
As an important source of high quality protein for human
consumption, cattle are considered to be one of the most
important domestic animals. At present, intensive produc-
tion systems have aggravated the health issues in cattle,
such as mastitis [1], acidosis [2, 3], metritis [4], as well as
welfare issues which have been leading to increasing food-
borne and zoonotic risks to humans and economic losses
for the industry. Due to the lack of validated early diagnosis
procedures, most diseases and disorders are usually
diagnosed at an advanced stage, and treatments for these
pathologies are often expensive and ineffective. Therefore,
there is an urgent need to identify reliable methods to diag-
nose the health status of cattle, which can then be used for
early detection and monitoring disease progression.
Accumulating evidences suggest that expression pat-
terns of microRNAs (miRNAs) in biofluids represent the
in vivo status of many physiological changes and diseases
[5–7], revealing that they can be served as diagnostic
markers for multiple human diseases including cancers
[8–11]. Blood is a non-invasive and the easiest obtained
biofluid, and miRNAs in blood hold great promise to
discover biomarkers for a wide range of diseases and
biological processes [12–15]. Whole blood was the most
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frequently used biofluid in detecting miRNAs, but the
outcomes could be biased due to the complexity of vari-
ous cell types and components [16, 17]. Recently, the
miRNAs in body fluids, such as plasma, serum, urine,
saliva and sputum [18–20] have been used as inform-
ative biomarkers to assess and monitor the body’s
physiological and pathological status due to their stabil-
ity even under extreme conditions in human [21, 22]. In
addition, it has been shown that the circulating miRNAs
from plasma and serum could serve as potential bio-
markers for livestock health and disease, such as miR-
26a for cattle early pregnancy [23], miR-19a and miR-
19b for cattle heat stress [24], miR-29c and miR-375 for
chicken puberty onset [25], and miR-122 for pig cardio-
genic shock [26].
These free circulating miRNAs can be protected from
nucleases by various types of carriers [27], such as exo-
somes. Exosomes are the most studied carriers, which
are small (30–90 nm) and derived from the multivesicu-
lar body-sorting pathway [28–30]. Recent researches
have proposed to use exosomal miRNAs for diagnositic
markers in human diseases [31], since the miRNAs in
exosomes have specific function and higher variability
than blood cells [16]. In addition, the quantity of miR-
NAs in exosomes exhibited more difference between
healthy individuals and cancer patients than that in sera
[27]. However, the exosomal miRNA profiling needs
extra steps in RNA extraction and which miRNAs (sera
vs. exosomes) are more representative for physiological
and health changes in cattle have not been defined.
The next-generation sequencing has made it possible
to obtain highly detailed information of miRNAs on the
types and abundance from various biomaterials [32].
However, consensus has not been reached with regard to
the sample types used for isolation of total RNA (such
as sera or exosomes), especially in cattle. To date, there
is little information on miRNAomes in bovine sera and
exosomes, which could be potential diagnostic bio-
markers relating to cattle health. Therefore, the aim of
the current study was to compare the bovine miR-
NAomes of sera and exosomes, and to provide insights
into their future applications.
Results
MiRNA profiles of sera and exosomes
An average of 9.25 ± 1.44 and 15.70 ± 12.43 ng small
RNAs were obtained from sera and exosomes (Table 1),
respectively. RNA sequencing resulted in 29,692,695
reads for sera and 6,581,761 reads for exosomes, respect-
ively. After quality and length filter, 22,745,381 reads
(76.6 %) in sera and 3,960,646 reads (60.2 %) in exo-
somes were used for further analysis (Additional file 1:
Table S1). In exosomes, higher proportion of reads failed
the size trimming compared to sera (39.9 % vs. 23.8 %).
After mapping to bovine genome (Baylor Btau 4.6.1), the
proportion of annotated miRNAs was 6.9 % in sera, and
11.3 % in exosomes (Fig. 1a). And the reads mapped to
tRNA, rRNA snoRNA and snRNA were low (< 1 %)
(Fig. 1a) from both sera and exosomes with large pro-
portion reads unidentified. Size distribution of the reads
between 19 and 40 nt revealed 2 peaks at 19–25 nt and
30–33 nt for both sample types (Fig. 1b).
Complexity and specificity of sera and exosomes
miRNAomes
The miRNAs that were detected in at least two cattle
with more than 1 reads per million total mapped reads
(RPM) in sera or exosomes were considered as expressed
miRNAs. Sera had higher number of miRNAs (328 ± 17)
expressed, while significantly less miRNAs (260 ± 15, P
= 0.001) were expressed in exosomes (Fig. 2a). The re-
spective miRNAomes of sera and exosomes are available
in Additional file 2: Table S2. Using principle component
analysis (PCA) it showed that the miRNAs profiles be-
tween sera and exosomes were different (Fig. 2b). More
uniquely expressed miRNAs were found in sera than
those in exosomes, with 24 and 3 uniquely expressed
miRNAs detected (with mean RPM > 5) in sera and exo-
somes, respectively (Table 2).
It was observed that 282 miRNAs were commonly
expressed in sera and exosomes (Fig. 2c), and their ex-
pression profiles had a high correlation of 0.97 (Fig. 2d).
From the commonly expressed miRNAs, the proportion
of the top 10 miRNAs accounted 95.6 and 96.2 % of
total reads for sera and exosomes, respectively, with the
same predominant miRNAs identified. The comparison
of the relative abundance of top 10 annotated miRNAs
showed that sera and exosomes had similar profiles of
abundant miRNAs except miR-191 in sera and miR-10b
in exosmes (Fig. 3a, b).
In addition, 12 miRNAs were differentially expressed
(DE) between sera and exosomes. The expression of
miR-361, miR-16a, miR-146b and miR-24-3p were
higher in sera, while the expression of other eight





Total small RNA ± SD
(ng)
Sera Total RNA Purification Kit (Norgen, Thorold, CA) 200 50 9.25 ± 1.44
Exosomes Total RNA Isolation Reagent and Total Exosome RNA and Protein Isolation Kit (Invitrogen,
Carlsbad, USA)
800 50 15.70 ± 12.43
Zhao et al. BMC Genomics  (2016) 17:630 Page 2 of 12
miRNAs (miR-328, miR-1249, miR-1306, miR-339b,
miR-339a, miR-296-5p, miR-21-3p and miR-92b) were
higher in exosomes (FDR < 0.05, Table 3).
Experimental validation of miRNA expression
A total of 10 uniquely expressed and DE miRNAs that
identified from miRNA-seq (four uniquely expressed
miRNAs in sera: miR-196b, miR-196a, miR-18b, and
miR-9-3p; two uniquely expressed miRNAs in exosomes:
miR-2284k and miR-9-5p; four DE miRNAs between
sera and exosomes: miR-146b, miR-24-3p, miR-328, and
miR-21-3p) were selected for validation using stem-loop
RT-qPCR. Three out of four DE miRNAs showed similar
trend as detected by miRNA-seq. Specifically, the ex-
pressions of miR-146b and miR-24-3p were highly
expressed in the sera, while miR-328 was highly
expressed in the exosomes by miRNA-seq and RT-qPCR
(P < 0.05) (Fig. 4 a-c). Although the expression of miR-
21-3p, detected by RT-qPCR showed no significant dif-
ference between sera and exosomes (P < 0.1), its expres-
sion was numerically higher in exosomes, which was
similar with the results detected by miRNA-seq (Fig. 4d).
However, the expression of those sera or exosomes
uniquely expressed miRNAs could not be detected by
RT-qPCR (CT value < 35), which may be due to their
low abundance and the relative low content of miRNAs
in serum.
Stability of the bovine sera and exosomes miRNAomes in
healthy animals
It is important to determine how miRNAomes varies
among individuals, especially for the healthy animals. As
the sera and exosomes were taken from the same four cat-
tle, the individual variation between sera and exosomes
reflected the stability of miRNAs in two types of samples.
The high correlation was observed with r = 0.96 for sera
(Additional file 3: Table S3) and r = 0.95 for exosomal
miRNAomes (Additional file 4: Table S4) among four ani-
mals. The hierarchical clustering analysis on the 50 most
variable miRNAs revealed that sera and exosomes were
clustered to different groups (Fig. 5).
Functional categories and pathways of uniquely
expressed and differentially expressed miRNAs in sera
and exosomes
Based on predicted targets of miRNAs using Targetscan
and mirRanda as well as functional analysis using In-
genuity Pathway Analysis (IPA), the functional categories
of miRNAomes in sera and exosomes were identified.
Further functional analysis of uniquely expressed miR-
NAs in sera and exosomes revealed 3,847 and 1,520
gene targets, respectively. Among the top 20 functions
of predicted gene targets of the uniquely expressed miR-
NAs in sera and exosomes, 14 functional categories were
common in two types of samples (Table 4). Besides the
common functions, the sera uniquely expressed miRNAs
targeted the function of diseases and disorders such as
neurological/infections diseases and skeletal, muscular,
hereditary and psychological disorders, while the exo-
somes uniquely expressed miRNAs packaged into exo-
somes targeted the function of tissue development and
lipid metabolism (Table 4).
There were 3,183 genes putatively targeting by the 12
DE miRNAs. Functional analysis revealed that most of the
functional categories were shared by the highly expressed
DE miRNAs in sera or exosomes (Table 5). Additionally,
the function of infectious disease and cell-mediated im-
mune response were targeted by sera enriched miRNAs,
Fig. 1 Profiling of small RNAs in cattle sera and exosomes samples. a The relative abundance of different classes of small RNAs. b Size and
frequency distribution of detected small RNAs (19-40 nt). SE Sera, EX Exosomes
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while the skeletal/muscular system development and lipid
metabolism were targeted by exosomes enriched miRNAs.
Besides, the most targeted pathways predicted based on
sera enriched miRNAs were LPS-stimulated MAPK sig-
naling, while the exosomes enriched miRNAs targeted
cancer pathways (Table 6).
Discussion
To date, the searching of blood miRNA biomarkers
mainly focused on the altered expression levels of
miRNAs in diseases. However, little is known about
their expression levels associated with the physiological
changes and composition of miRNAome, especially in
cattle. Here, we conducted a comprehensive miR-
NAome comparison between cattle sera and exosomes
that have been commonly used in miRNA studies.
While surveying the profiles of cell-free small RNAs in
cattle, we observed that the annotated miRNAs were low
from the sequencing datasets. Size distribution of the total
reads revealed two peaks in sera and exosomes, which is
similar as reported in the blood samples of mouse and hu-
man [33, 34]. The nucleic acid fragments ranging 19–25 nt
were mostly annotated as miRNAs. It has been reported
that, in addition to miRNAs, several classes of small RNAs
mediated multiple biological functions, including siRNAs
(20–24 nt), piRNAs (25–32 nt), and others that bound by
Argonaute proteins also could be detected in blood
[35–37]. Moreover, studies on the processed small RNAs,
such as 5’ tRNA halves and and 5’ YRNA fragments (30–
33 nt) suggested that they were abundant in circulating
small RNAs and might act as novel form of signaling mol-
ecules [38, 39]. Thus, it is postulated that the 30–33 nt
peak in our study might be processed small RNAs.
Fig. 2 Complexity of miRNAs detected in the sera and exosomes. a Average number of miRNAs expressed in sera and exosomes, different letters
(a, b) represent significant difference (P < 0.05). b Principle component analysis of the total detected miRNAs in sera and exosomes (blue dots
represent sera, red dots represent exosomes). c Venn diagram showing the profile of miRNAs expressed in sera and exosomes. d Correlation
analysis of the commonly expressed miRNAs in sera and exosomes
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The miRNAs detected in exosomes represented about
78 % of total miRNAs expressed in sera, suggesting exo-
somes are the major carriers for miRNAs in bovine sera.
In particular, there were 282 miRNAs expressed in all
individuals with high correlation between sera and exo-
somes, indicating those miRNAs may play important
roles in extra-cellular blood fluid of cattle. MiR-486,
miR-92a, miR-16, miR-144, and miR-451 have been
commonly applied as erythrocyte markers for human
and mice [40, 41], and they were all expressed in our bo-
vine sera and exosomes dataset with high proportion.
Besides, miR-22-3p, the secondly abundant miRNA in
sera (12.0 %) and exosomes (10.4 %), was miRNA bio-
marker expressed by myeloid [42]. Therefore, red blood
cells and myeloid might contribute significantly to circu-
lating miRNAs and this could have important implica-
tions for circulating miRNA biomarker studies. Some of
top abundance miRNAs detected in bovine sera were
not abundant ones in human [17], vice versa, which were
Table 3 Differentially expressed miRNAs in sera and exosomes
miRNA ID Log2 FC Log2 RPM P Value FDR
bta-miR-361 1.03 9.72 3.01E-05 1.10E-03
bta-miR-16a 1.19 12.13 3.00E-04 7.50E-03
bta-miR-146b 1.89 6.69 3.00E-04 6.30E-03
bta-miR-24-3p 2.06 9.91 1.62E-10 1.08E-08
bta-miR-328 −2.93 8.40 5.74E-14 5.07E-12
bta-miR-1249 −2.74 4.97 2.00E-04 6.20E-03
bta-miR-1306 −2.44 7.44 1.44E-06 6.36E-05
bta-miR-339b −2.29 9.87 3.19E-19 5.29E-17
bta-miR-339a −2.29 9.87 3.99E-19 5.29E-17
bta-miR-296-5p −2.09 5.40 2.00E-04 5.60E-03
bta-miR-21-3p −1.76 9.12 7.43E-09 3.94E-07
bta-miR-92b −1.16 10.74 2.00E-04 6.20E-03
Fig. 3 The pie chart of ten most abundant miRNAs. a Sera. b
Exosomes. MiRNAs differed in two samples were colored in red
Table 2 Unique miRNAs expressed in bovine sera and
exosomes
Sera Exosomes
miRNA ID Mean RPM ± SD miRNA ID Mean RPM ± SD
bta-miR-493 16.39 ± 12.03 bta-miR-2284k 8.15 ± 6.87
bta-miR-196b 16.25 ± 5.54 bta-miR-6533 7.29 ± 8.56
bta-miR-1271 15.74 ± 4.79 bta-miR-9-5p 7.29 ± 8.56
bta-miR-708 13.41 ± 6.50
bta-miR-628 13.09 ± 3.25
bta-miR-18b 13.02 ± 7.63
bta-miR-2285b 12.26 ± 3.69
bta-miR-187 11.03 ± 15.55
bta-miR-7861 10.96 ± 8.15
bta-miR-95 9.88 ± 6.55
bta-miR-543 9.61 ± 6.82
bta-miR-424-3p 7.08 ± 6.55
bta-miR-2299-3p 7.02 ± 8.54
bta-miR-2448-3p 7.01 ± 3.55
bta-miR-592 6.91 ± 5.45
bta-miR-369-5p 6.44 ± 6.96
bta-miR-2447 6.42 ± 8.91
bta-miR-29d-5p 5.89 ± 5.02
bta-miR-545-3p 5.55 ± 4.92
bta-miR-9-3p 5.29 ± 6.72
bta-miR-376b 5.18 ± 4.15
bta-miR-495 5.13 ± 5.23
bta-miR-183 5.08 ± 5.94
bta-miR-196a 5.08 ± 5.94
The expression is presented as reads per million (RPM) with Mean RPM > 5.
SD Standard deviation
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not found in bovine sera. The inconsistence in miRNA
spectrums might come from the different erythropoiesis
between human and bovine [42].
At present, little is known about the origin and destination
of these sera/exosomes miRNAs in the circulatory system.
Based on identified miRNA profiles, our results showed that
spectra of miRNAomes were different between sera and
exosomes, and miRNAome of sera was more complex than
that of exosomes. The complexity of sera miRNAomes is
reasonable, because circulating miRNAs were bounded to
various carriers including exosomes, proteins, lipoprotein
particles, and cell-derived extracellular vesicles [28, 29, 43].
For example, it has been reported that Argonaute2 com-
plexes carried a population of circulating miRNAs inde-
pendent of vesicles in human plasma [44]. It is noticeable
that the sera miRNAomes detected in this study may also
contain the exosome miRNAs. To precisely identify sera
specific miRNAs, sera-depletion from exosomes using size-
exclusion chromatography in the future studies will provide
the detailed contribution and function of the different
circulating miRNAs components in sera. In addition, the
unique origin may contribute to the miRNAs patterns in
sera and exosomes. The assumption above could be sup-
ported by the fact that 24 and 3 miRNAs were exclusively
expressed with high level in sera and exosomes, respectively.
In addition, 12 miRNAs were differentially expressed be-
tween two samples. Because of their distinct profiles, miR-
NAs from sera and exosomes might reflect different aspects
of physiological and pathological conditions in cattle.
Many miRNAs are evolutionarily conserved [45].
Therefore, information from human studies on the
highly conserved miRNAs that have important roles in
regulating health may also be applied to cattle. For ex-
ample, miR-196, which was uniquely expressed in sera,
has recently been reported to be involved in the antiviral
immunity in human [46]. And antiviral interferon re-
sponse could induce the expression of miR-196, which
then inhibited the gene expression and replication of
hepatitis C virus [47, 48]. Mitogen activated protein
kinases (MAPK) are a group of signaling molecules that
Fig. 4 Expression of selected DE miRNAs between sera and exosomes detected by RT-qPCR and miRNA-seq. a Expression of miR-146b; b Expres-
sion of miR-24-3p; c Expression of miR-328; d Expression of miR-21-3p. miRNA expression from RT-qPCR represented by lines on the top and
values are shown on the right vertical axis as relative abundance. miRNA expression from miRNA-seq represented by bars on the bottom and
values are shown on the left vertical axis as log2RPM (normalized reads number). * on the top of lines or bars indicate significant (P < 0.05 or FDR
< 0.05) difference between sera and exosomes. Data are presented as Mean ± Standard deviation
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play important roles in the inflammatory processes [49–51].
Together with LPS-stimulated MAPK pathway that is the
most enriched for up-regulated miRNAs in sera, our results
suggest that sera uniquely expressed miRNAs (such as miR-
196) may play important roles in regulating inflammation
and immune response in cattle. MiR-9 is a brain specific
miRNA [52], and we found that miR-9-3p and miR-9-5p
was uniquely expressed in bovine sera and exosomes, re-
spectively. The differential enrichment of miR-9-3p and
miR-9-5p further demonstrated the specific function of sera
and exosomes. In addition, miR-92b was differentially
expressed between sera and exosomes, with higher expres-
sion in exosomes. Nass et al. reported that miR-92b was
specifically expressed in the heart and muscle, and overex-
pression of miR-92b reduced Mef2 levels and caused muscle
attachment defects [53]. In addition, miR-92b and miR-9
were over-expressed in developing brain and neuronal stem
cells compared to the adult brain, and thus have been
implicated as players in human nervous system develop-
ment [54, 55]. These suggest that exosomes uniquely
expressed and/or highly expressed miRNAs may be used as
markers to study changes in development.
The high correlation of expression profiles among in-
dividuals was observed, demonstrating the low individual
variation of miRNAs in bovine extra-cellular blood fluid,
the reasonable approach of sera/exosomes sample prep-
aration and miRNA profiling in this study. Overall, the
identified expression of miRNAs in sera and exosomes
enabled an insight into the basis miRNAs pattern of
healthy cattle, which provides a strong basis to inform
the further investigation of circulating miRNAomes as
biomarkers in cattle.
Conclusion
Using RNA-seq, our results revealed that 1) exosomes
showed a less complex with respect to the miRNAomes
as compared to sera; 2) sera and exosomes had their
specificities in profiling of miRNAs, which may reflect
different aspects of physiological and pathological con-
ditions in cattle; 3) exosomes were major miRNAs car-
riers in cattle sera, and both samples could be used as
potential candidates in biomarker study for different
goals in future. Nevertheless, this study laid a founda-
tion for understanding the dysregulations diverging
Fig. 5 Heatmap generated by clustering of the 50 most variable miRNAs in sera (SE) and exosomes (EX) from four cattle. Colors represent
different normalized sequencing reads number as indicated by the color bar (Log2RPM)
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from ordinary physiology by providing information
about miRNAomes of healthy individual of bovine sera
and exosomes. Furthermore, our results provide the
guidance in selection of sample type for particular
goals in cattle miRNAs study. Based on our prelimin-
ary findings, sera may be preferable for selecting bio-
markers of heath such as disease, while exosomes may
be better for monitoring the muscle development and
lipid metabolism, which should be validated in the fu-




The whole blood samples were collected from 4 healthy
lactating Holstein cow (33 ± 7 mon, 654 ± 54 kg; mean
± SD). All cows had normal milk production and intake
and did not have any incidence of health related issues
(data not shown). Experimental protocols were
reviewed and approved by the Livestock Animal Care
Committee of the University of Alberta and all proce-
dures were conducted following the guidelines of Can-
adian Council on Animal Care. Briefly, 9 mL whole
blood was collected in S-Movovette Sera-Gel tubes
(Sarstedt, Nümbrecht, Germany) containing clot activa-
tor, and then the samples were incubated at room
temperature for 1 h. The whole blood samples were
firstly centrifuged at 4 °C (1,900 × g, 10 min), followed
by a second centrifugation at 4 °C (16,000 × g, 10 min).
After this step, the circulating cell-free nucleic acid
were in the supernatant (sera) and then the sera were
transferred into a fresh 2.0 mL tube and stored at -80 °
C for further analysis.
Total RNA isolation
Total RNA in sera was extracted using Total RNA
Purification kit (Norgen, Thorold, CA) following man-
ufacturer’s protocols. For exosomal RNA extraction,
exosomes were firstly isolated from the same sera sam-
ples using the Total Exosomes Isolation kit (Invitrogen,
Carlsbad, CA), and then the total RNA was extracted
using Total Exosome RNA and Protein Isolation Kit
(Invitrogen, Carlsbad, CA). The concentration of RNA
was determined using the Qubit microRNA assay kit
and the 2.0 Fluorometer (Invitrogen, Carlsbad, CA).
The RNA samples were stored at -80 °C for further
analysis.
Table 4 Top 20 functional categories of predicted gene targets by uniquely expressed miRNAs in sera and exosomes
Sera Exosomes
Category B-H p-value Category B-H p-value
Cellular Growth and Proliferation 1.27E-28-1.11E-03 Cellular Growth and Proliferation 2.76E-12-6.05E-02
Cancer 4.54E-24-1.01E-03 Cancer 1.26E-08-6.05E-02
Organismal Injury and Abnormalities 4.54E-24-1.11E-03 Organismal Injury and Abnormalities 1.26E-08-6.05E-02
Cell Death and Survival 5.07E-24-1.01E-03 Cell Morphology 1.67E-08-6.05E-02
Organismal Survival 5.07E-24-2.65E-06 Organismal Survival 3.05E-08-2.39E-02
Cellular Assembly and Organization 7.61E-20-4.99E-04 Cellular Assembly and Organization 6.75E-07-6.05E-02
Cellular Function and Maintenance 7.61E-20-8.07E-04 Cellular Function and Maintenance 6.75E-07-6.05E-02
Cell Morphology 8.22E-19-7.27E-04 Cellular Movement 3.04E-06-6.03E-02
Molecular Transport 2.63E-16-9.67E-04 Cell Death and Survival 3.43E-06-6.03E-02
Cellular Movement 2.28E-15-1.05E-03 Gastrointestinal Disease 6.85E-06-6.03E-02
Cellular Development 4.18E-15-1.09E-03 Cardiovascular System Development and
Function
8.40E-06-6.03E-02
Neurological Disease 3.21E-13-1.11E-03 Molecular Transport 9.36E-06-6.04E-02
Gene Expression 3.57E-13-3.95E-04 Cellular Development 9.36E-06-5.83E-02
Cardiovascular System Development and Function 3.57E-13-1.13E-03 Connective Tissue Development and
Function
9.36E-06-5.48E-02
Organismal Development 4.85E-13-1.01E-03 Organismal Development 9.36E-06-6.03E-02
Gastrointestinal Disease 1.43E-12-8.91E-04 Nervous System Development and
Function
1.82E-05-5.83E-02
Infectious Disease 1.63E-12-6.47E-04 Tissue Development 1.82E-05-5.83E-02
Skeletal and Muscular Disorders 3.74E-12-1.13E-03 Organ Morphology 5.23E-05-6.03E-02
Hereditary Disorder 8.81E-12-8.81E-12 Lipid Metabolism 5.97E-05-6.03E-02
Psychological Disorders 8.81E-12-7.60E-11 Small Molecule Biochemistry 5.97E-05-6.03E-02
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Library construction and sequencing
Total RNA (5 μL) from each sample was used to con-
struct miRNA library using the TruSeq Small RNA Sam-
ple Preparation Kit (Illumina, San Diego, CA) according
to the manufacturer’s instruction. Small RNA libraries
were then pooled together in equal volumes for gel puri-
fication. The pooled library was sequenced at Génome
Québec (Montréal, Canada) using the Illumina HiSeq
2000 system (Illumina) as 50 bp single reads.
Small RNA sequence analysis
Low-quality reads were removed from raw data using
CASAVA 1.8 based on chastity. High-quality reads were
then subjected to sRNAbench for adaptor sequence
Table 6 Predicted pathways targeted by miRNAs differentially expressed in sera and exosomes
P Genes present in pathway (%) Molecule
Sera
LPS-stimulated MAPK Signaling 4.11E-06 24.7 18
Molecular Mechanisms of Cancer 1.40E-05 13.7 51
UVC-Induced MAPK Signaling 3.39E-05 28.6 12
IL-17A Signaling in Gastric Cells 4.32E-05 36.0 9
Notch Signaling 6.28E-05 28.9 11
Exosomes
Molecular Mechanisms of Cancer 2.48E-10 20.1 75
β Cell Receptor Signaling 3.39E-08 23.2 42
Integrin Signaling 3.53E-08 22.4 45
NGF Signaling 3.65E-08 27.4 31
HGF Signaling 4.43E-08 27.8 30
Table 5 Top 20 functions of predicted gene targets of differentially expressed miRNAs in sera and exosomes
Highly expressed miRNAs in sera Highly expressed miRNAs in exosomes
Category B-H p-value Category B-H p-value
Cellular Assembly and Organization 6.09E-06-9.75E-02 Cell Death and Survival 6.84E-14-3.44E-02
Cellular Function and Maintenance 6.09E-06-9.75E-02 Cellular Assembly and Organization 8.85E-14-2.77E-02
Molecular Transport 1.09E-05-9.68E-02 Cellular Function and Maintenance 8.85E-14-3.45E-02
Cancer 6.32E-05-9.68E-02 Cellular Growth and Proliferation 4.07E-13-3.45E-02
Cell Death and Survival 9.31E-05-9.68E-02 Cell Morphology 1.09E-10-3.34E-02
Organismal Survival 9.31E-05-6.44E-02 Cellular Movement 8.05E-09-2.79E-02
Cellular Growth and Proliferation 9.31E-05-9.75E-02 Cancer 2.61E-08-3.24E-02
Cell Morphology 2.20E-04-9.75E-02 Molecular Transport 4.45E-07-3.21E-02
Cardiovascular System Development and Function 2.94E-04-9.68E-02 Cardiovascular System Development
and Function
8.40E-07-3.43E-02
Organismal Development 2.94E-04-9.68E-02 Organismal Development 8.40E-07-3.45E-02
Infectious Disease 7.70E-04-9.68E-02 Organismal Survival 1.38E-06-2.44E-02
Gene Expression 7.70E-04-9.68E-02 Tissue Development 1.79E-05-3.34E-02
Cellular Movement 8.00E-04-9.68E-02 Gene Expression 2.31E-05-2.13E-02
Cell-mediated Immune Response 1.23E-03-9.68E-02 Cellular Development 2.89E-05-3.45E-02
Cellular Development 1.23E-03-9.75E-02 Nervous System Development and
Function
5.47E-05-3.23E-02
Hematological System Development and Function 1.23E-03-9.75E-02 Skeletal and Muscular System Development
and Function
6.43E-05-3.23E-02
Hematopoiesis 1.23E-03-9.75E-02 Neurological Disease 6.97E-05-3.18E-02
Lymphoid Tissue Structure and Development 1.23E-03-9.75E-02 Lipid Metabolism 1.19E-04-3.18E-02
Tissue Development 1.82E-03-9.75E-02 Small Molecule Biochemistry 1.19E-04-3.21E-02
Connective Tissue Development and Function 2.01E-03-9.75E-02 Psychological Disorders 1.55E-04-2.44E-02
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trimming and reads length distribution analysis [56].
The sequences with read length larger than 15 nt were
aligned against bovine miRNA database (miRBase, re-
lease version 21) with the default parameters to identify
known miRNAs using sRNAbench. Each library was
processed separately. The expression level of miRNAs in
each library was estimated by sRNAbench, which nor-
malized reads count number of each miRNA RPM by
the following formula: RPM= (miRNA reads number/
total mapped reads per library) × 1,000,000. Correlations
were calculated using the Pearson method in R software
(version 3.0). The differentially expressed (DE) miRNAs
were investigated by using bioinformatics tool edgeR
[57]. The DE miRNAs were determined by Log2 fold
change (FC) >1 or < -1 and false discovery rate (FDR) <
0.05 based on Benjamini and Hochberg multiple testing
correction [58].
Target gene prediction and functional analysis
The functional analysis of selected miRNAs was performed
following a previous study [59]. Briefly, target genes of se-
lected miRNAs were commonly predicted by TargetScan
Relase 6.0 (http://www.targetscan.org/) [60] and miRanda
(http://www.microrna.org/microrna/home.do). Then the
predicted target genes were analyzed through IPA using
core analysis module (www.ingenuity.com). A threshold of
FDR < 0.05 and molecule number > 1 were used to enrich
significant biological functions of each miRNA.
Experimental validation of miRNA expression using stem-
loop RT-qPCR
The expression of uniquely expressed and DE miRNAs
that were identified by miRNA-seq were validated by
stem-loop RT-qPCR using TAQMAN miRNA assays fol-
lowing the manufacturer’s instruction (Applied Biosys-
tems, Foster City, CA). Briefly, cDNAs were reverse
transcribed from 5 μL of total RNA using 5 X specific
miRNA RT primer and then were amplified using a 20
X TAQMAN miRNA assay. Fluorescence signal was
detected with StepOnePlus™ Real-Time PCR System
(Applied Biosystems, Foster City, CA). In this study,
miR-93 was used as an internal reference to calculate
the relative expression of target miRNA using the 2-ΔΔCT
(cycle threshold, CT) method [61]. This miRNA was se-
lected due to its stable expression between sera and exo-
somes after comparing with the most used reference U6
[62, 63], and previously reported serum miRNA refer-
ence candidates miR-127 and miR-744 in bovine and
mouse [64, 65]. In addition, no difference was observed
between sera and exosomes in miR-93 expression de-
tected by RNA-seq (P > 0.05). Differences were consid-
ered statistically different at P < 0.05 and analysis were
performed using t-test.
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